Unternehmensübersicht
Zhongchao Inc. operates within the healthcare sector, specifically serving the Health Information Services industry by delivering specialized healthcare information, education, and training services to professionals in the People's Republic of China under its MDMOOC brand. The company's operational scope extends to two distinct segments, encompassing MDMOOC services and the sales of patented drugs, alongside offering patient management services. As a market participant, Zhongchao Inc. holds a market capitalization of $7.42M and reports an annual revenue of $11.37M, while specific employee headcount data is not publicly disclosed. These valuation and revenue figures indicate that the company operates as a small-cap entity with a relatively modest market footprint, suggesting a niche position within the broader Chinese healthcare services landscape rather than a dominant market leader. The combination of service-based revenue and patented drug sales highlights a diversified operational model that seeks to mitigate risks associated with relying on a single revenue stream within the volatile healthcare sector.
Finanzielle Gesundheit
The financial performance of Zhongchao Inc. over the trailing twelve months (TTM) is characterized by a revenue of $11.37M, a net income of $-6,310,153, and an EBITDA of $-5,901,042. The substantial negative net income relative to the positive revenue stream reveals a significant gap that points to a high-cost structure, likely driven by heavy investments in operations, research, or administrative expenses that are not yet covered by gross profits. The company generates a free cash flow of $-1,112,632, which indicates that its current operational activities are consuming cash reserves rather than generating liquidity, thereby limiting immediate financial flexibility for external expansion or capital expenditures. Margin analysis shows a gross margin of 45.0%, which suggests a moderate ability to control the cost of goods sold, but this is offset by an operating margin of -92.0% and a profit margin of -55.5%, reflecting severe inefficiencies in covering overhead costs and overall profitability issues. On the balance sheet, the company holds $13.92M in cash against $26,083 in debt, resulting in a debt-to-equity ratio of 0.12, which demonstrates an extremely conservative capital structure with negligible leverage and minimal interest burden. The current ratio stands at 11.11, indicating an exceptionally strong short-term liquidity position where current assets far exceed current liabilities, providing ample buffer for meeting immediate obligations despite operational cash burn. Furthermore, the return on equity is -24.9% and the return on assets is -15.5%, metrics that reveal that management effectiveness is currently constrained by the company's inability to generate positive returns on the capital deployed by shareholders and utilized in its asset base.
Bewertungsanalyse
Valuation multiples for Zhongchao Inc. are unavailable in traditional earnings terms, as the P/E Ratio (TTM) is N/A and the Forward P/E is N/A, implying that investors cannot value the stock based on current or projected earnings power due to the company's consistent losses. The price-to-book ratio is 0.30, which indicates that the market is pricing the company at a significant discount to its net asset value, suggesting that the market perceives substantial intangible risks or expects a long period before the asset base can generate positive cash flows. Alternative valuation metrics provide further insight, with a price-to-sales ratio of 0.65 and an EV/EBITDA of 0.42, figures that suggest the market is willing to pay a fraction of sales value, reflecting a speculative stance on future turnaround potential rather than current profitability. In terms of price volatility, the stock has traded between a 52-week low of $1.44 and a 52-week high of $12.18; without a specific current share price, the range demonstrates extreme fluctuation, but the beta value is N/A, meaning volatility relative to the broader market index cannot be quantified based on available data. The absence of a forward P/E compared to the trailing P/E (both N/A) implies that analysts lack confidence in forecasting a near-term earnings trajectory that would allow for traditional multiple-based valuation models to be applied effectively.
Growth & Income
The growth profile of Zhongchao Inc. shows a revenue growth (YoY) of -23.2%, while earnings growth (YoY) is N/A due to the lack of positive earnings history to benchmark against. The decline in revenue indicates a contraction in the core business operations, and the absence of positive earnings growth further confirms that the company is in a contractionary phase rather than an expansionary one. Regarding income distribution, the company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which means the company retains all its earnings—though currently negative—for reinvestment or to cover operational losses rather than returning capital to shareholders. Consequently, the overall growth and income profile is defined by revenue contraction and a lack of income generation, positioning the stock purely as a speculative play on a potential future recovery of the healthcare services business in China without the cushion of dividend income or stable earnings growth to support the valuation.